← Leaderboards
Michael P McGrogan
Layton Bioscience, Inc.
$1,484,934
Attributed
$1,484,934
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,484,934 · 3
By mechanism
R44$1,384,934 · 2
R43$100,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Layton Bioscience, Inc.
Same institution · by research overlap
- Karen S Aboody$8,965,368
- Alison E Willing$2,801,388
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsNervous System TransplantationImmunocytochemistryTechnology /Technique DevelopmentCell DifferentiationBiotechnologyTissue /Cell CultureNeural PlasticityTissue /Cell PreparationCell TransplantationSpinal CordSpinal Cord InjurySpinal Cord SurgeryAstrocytomaMorphologyNeoplastic CellNerve Stem CellNeurogenesisOncoproteinsReporter GenesStem CellsStroke TherapyMass Tissue /Cell CultureAthymic Mouse
Grant awards (4)
OPTIMIZE HUMAN NEURONAL CELLS FOR SPINAL CORD TRANSPLANT$487,814
R44 · FY2002 · NS
HUMAN NEURAL STEM CELLS TARGET GENE THERAPY-BRAIN TUMORS$422,314
R44 · FY2002 · CA
OPTIMIZE HUMAN NEURONAL CELLS FOR SPINAL CORD TRANSPLANT$474,806
R44 · FY2001 · NS
PRODUCING HUMAN NEURONAL CELLS TO TREAT STROKE$100,000
R43 · FY2000 · NS